close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Bio-Rad Laboratories, Inc.

< Previous 1 2 Next >
Bio-Rad’s Chief Operating Officer Andrew Last to Retire
From Bio-Rad Laboratories, Inc.
Via Business Wire
Tickers BIO
Bio-Rad Appoints Roop K. Lakkaraju Executive Vice President, Chief Financial Officer
From Bio-Rad Laboratories, Inc.
Via Business Wire
Tickers BIO
Bio-Rad to Participate in Fireside Chat During Citi's 2024 Unplugged Medtech and Life Sciences Access Day
From Bio-Rad Laboratories, Inc.
Via Business Wire
Tickers BIO
Bio-Rad Reports Fourth-Quarter and Full-Year 2023 Financial Results
From Bio-Rad Laboratories, Inc.
Via Business Wire
Tickers BIO
Bio-Rad to Report Fourth Quarter and Full Year 2023 Financial Results on Thursday, February 15, 2024
From Bio-Rad Laboratories, Inc.
Via Business Wire
Tickers BIO
Bio-Rad’s Management to Host Investor Meetings at J.P. Morgan’s 42nd Annual Healthcare Conference
From Bio-Rad Laboratories, Inc.
Via Business Wire
Tickers BIO
Bio-Rad Reports Third-Quarter 2023 Financial Results
From Bio-Rad Laboratories, Inc.
Via Business Wire
Tickers BIO
Bio-Rad to Report Third Quarter 2023 Financial Results on Thursday, October 26, 2023
From Bio-Rad Laboratories, Inc.
Via Business Wire
Tickers BIO
Bio-Rad to Participate in Fireside Chat During Wells Fargo’s 2023 Healthcare Conference
From Bio-Rad Laboratories, Inc.
Via Business Wire
Tickers BIO
Bio-Rad Reports Second-Quarter 2023 Financial Results
From Bio-Rad Laboratories, Inc.
Via Business Wire
Tickers BIO
Bio-Rad and QIAGEN Announce Patent Settlement and Cross-Licensing Agreement
From Bio-Rad Laboratories, Inc.
Via Business Wire
Tickers BIO QGEN
Bio-Rad Announces New Share Repurchase Program
From Bio-Rad Laboratories, Inc.
Via Business Wire
Tickers BIO
Bio-Rad to Report Second Quarter 2023 Financial Results on Thursday, August 3, 2023
From Bio-Rad Laboratories, Inc.
Via Business Wire
Tickers BIO
Bio-Rad Publishes Corporate Sustainability Report for 2022
From Bio-Rad Laboratories, Inc.
Via Business Wire
Tickers BIO
Bio-Rad to Present Company Overview at Jefferies Healthcare Conference
From Bio-Rad Laboratories, Inc.
Via Business Wire
Tickers BIO
Bio-Rad to Participate in Fireside Chat During 2023 RBC Capital Markets Global Healthcare Conference
From Bio-Rad Laboratories, Inc.
Via Business Wire
Tickers BIO
Bio-Rad Reports First-Quarter 2023 Financial Results
From Bio-Rad Laboratories, Inc.
Via Business Wire
Tickers BIO
Bio-Rad to Report First Quarter 2023 Financial Results on Thursday, May 4, 2023
From Bio-Rad Laboratories, Inc.
Via Business Wire
Tickers BIO
Bio-Rad to Participate in Citi’s 2023 Healthcare Services, MedTech, Tools & HCIT Conference
From Bio-Rad Laboratories, Inc.
Via Business Wire
Tickers BIO
Bio-Rad Reports Fourth-Quarter and Full-Year 2022 Financial Results
From Bio-Rad Laboratories, Inc.
Via Business Wire
Tickers BIO
Bio-Rad to Report Fourth Quarter and Full Year 2022 Financial Results on Thursday, February 16, 2023
From Bio-Rad Laboratories, Inc.
Via Business Wire
Tickers BIO
Bio-Rad to Present Company Overview at J.P. Morgan 41st Annual Healthcare Conference
From Bio-Rad Laboratories, Inc.
Via Business Wire
Tickers BIO
Bio-Rad To Participate in Fireside Chat During Credit Suisse’s 31st Annual Healthcare Conference
From Bio-Rad Laboratories, Inc.
Via Business Wire
Tickers BIO
Bio-Rad Reports Third-Quarter 2022 Financial Results
From Bio-Rad Laboratories, Inc.
Via Business Wire
Tickers BIO
Bio-Rad to Report Third Quarter 2022 Financial Results on Thursday, October 27, 2022
From Bio-Rad Laboratories, Inc.
Via Business Wire
Tickers BIO
Bio-Rad Acquires Curiosity Diagnostics
From Bio-Rad Laboratories, Inc.
Via Business Wire
Tickers BIO
Bio-Rad Reports Second-Quarter 2022 Financial Results
From Bio-Rad Laboratories, Inc.
Via Business Wire
Tickers BIO
Bio-Rad to Report Second Quarter 2022 Financial Results on Thursday, July 28, 2022
From Bio-Rad Laboratories, Inc.
Via Business Wire
Tickers BIO
Bio-Rad Publishes Corporate Sustainability Report
From Bio-Rad Laboratories, Inc.
Via Business Wire
Tickers BIO
Bio-Rad Reports First-Quarter 2022 Financial Results
From Bio-Rad Laboratories, Inc.
Via Business Wire
Tickers BIO
< Previous 1 2 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at $3.75/week.

Subscribe Today